Related Experiment Video
Updated: Dec 10, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
Masako Yumura1, Tatsuya Nagano1, Yoshihiro Nishimura1
1Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Abstract:
In recent years, multitarget drugs for neurological diseases such as Alzheimer's disease have been developed and well researched. Many studies have revealed that multitarget drugs are also useful for lung cancer and respiratory diseases. Pemetrexed is a multitargeted antifolate with strong antitumor activity against mesothelioma and lung adenocarcinoma. Crizotinib is an ATP-competitive tyrosine kinase inhibitor that targets c-MET, ROS1, and ALK. Alectinib is known as an ALK inhibitor but also targets LTK, CHEK2, FLT3, PHKG2, and RET. Sorafenib is a tyrosine kinase inhibitor that targets RAF kinase, KIT, VEGFR, PDGFR1β, FLT3, and RET. Nintedanib is a multiple tyrosine kinase inhibitor that targets FGFR, PDGFR, and VEGFR. In this review, we summarize the mechanisms of action of multitarget therapies and report the results of the latest clinical trials.
Insights
Multitarget drugs show promise for neurological diseases, lung cancer, and respiratory conditions. This review highlights their mechanisms and recent clinical trial outcomes for these diseases.
Area of Science:
- Oncology
- Pharmacology
- Neurology
Background:
- Multitarget drugs are increasingly researched for neurological diseases like Alzheimer's.
- These therapies also demonstrate efficacy in treating lung cancer and respiratory diseases.
Purpose of the Study:
- To review the mechanisms of action for multitarget therapies.
- To report the latest clinical trial results for multitarget drugs.
Main Methods:
- Literature review of multitarget drugs.
- Analysis of drug mechanisms and clinical trial data.
Main Results:
- Pemetrexed, Crizotinib, Alectinib, Sorafenib, and Nintedanib are discussed as examples of multitarget drugs.
- These drugs target various pathways including tyrosine kinases and antifolates.
- Clinical trials show potential in treating mesothelioma, lung adenocarcinoma, and other conditions.
Conclusions:
- Multitarget therapies offer a promising approach for complex diseases.
- Further research and clinical trials are essential to fully realize their therapeutic potential.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Tumor Immunotherapy
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment Resistant Cancers

